Category: Inclusion Body Myositis

Inclusion Body Myositis What Research is Being Done


Inclusion Body Myositis (IBM) is a condition that causes muscles to become thin and weak. Symptoms usually start in middle to late life and it is the most common muscle disease diagnosed after the age of 50. Nevertheless, it is still considered rare with between 3 and 4 people out of every 100,000 people over …

Continue reading

Inclusion Body Myositis New Treatment

Inclusion Body Myositis

A new drug to treat the muscle wasting disease inclusion body myositis (IBM) reverses key symptoms in mice and is safe and well-tolerated in patients, finds a new study led by the Medical Research Council Centre for Neuromuscular Diseases at UCL and the University of Kansas Medical Center. The study, published in Science Translational Medicine, …

Continue reading

Inclusion Body Myositis – Inflammatory Myopathies

What Is Inclusion Body Myositis? Inclusion body myositis is basically one of a group of diseases related to muscles known as inflammatory myopathies, characterized by progressive, chronic muscle inflammation which is accompanied by weakness of the muscles. Onset weakening of the muscle in Inclusion Body Myositis is usually gradual and affects both distal and proximal muscles. …

Continue reading